ArTS Archivio della ricerca di Trieste

STOCCO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.067
EU - Europa 6.886
AS - Asia 2.675
SA - Sud America 159
AF - Africa 69
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.885
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.007
PL - Polonia 2.387
IT - Italia 1.367
SG - Singapore 984
SE - Svezia 720
CN - Cina 710
HK - Hong Kong 511
DE - Germania 450
UA - Ucraina 400
FI - Finlandia 293
RU - Federazione Russa 268
NL - Olanda 196
TR - Turchia 164
IE - Irlanda 157
BG - Bulgaria 134
FR - Francia 126
BR - Brasile 125
GB - Regno Unito 120
IN - India 62
BE - Belgio 56
JP - Giappone 50
VN - Vietnam 46
AT - Austria 41
SN - Senegal 39
KR - Corea 30
CA - Canada 25
MX - Messico 22
AU - Australia 19
ES - Italia 19
PK - Pakistan 18
CH - Svizzera 17
CZ - Repubblica Ceca 17
PT - Portogallo 17
IR - Iran 13
AR - Argentina 12
GR - Grecia 12
DK - Danimarca 11
SI - Slovenia 11
EG - Egitto 10
NO - Norvegia 9
RO - Romania 9
TH - Thailandia 9
SA - Arabia Saudita 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CL - Cile 7
LT - Lituania 7
PE - Perù 7
RS - Serbia 7
TN - Tunisia 7
MY - Malesia 6
MD - Moldavia 5
NZ - Nuova Zelanda 5
PH - Filippine 5
SK - Slovacchia (Repubblica Slovacca) 5
EE - Estonia 4
HU - Ungheria 4
ID - Indonesia 4
IL - Israele 4
IQ - Iraq 4
JO - Giordania 4
KZ - Kazakistan 4
PR - Porto Rico 4
AL - Albania 3
CR - Costa Rica 3
DZ - Algeria 3
EU - Europa 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
LU - Lussemburgo 3
LV - Lettonia 3
PA - Panama 3
ZA - Sudafrica 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CO - Colombia 2
GH - Ghana 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
MT - Malta 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GE - Georgia 1
IS - Islanda 1
JM - Giamaica 1
LB - Libano 1
LS - Lesotho 1
MA - Marocco 1
MN - Mongolia 1
MW - Malawi 1
NG - Nigeria 1
Totale 18.882
Salva come PNG Salva come JPEG
Città #
Warsaw 2.371
Woodbridge 1.051
Fairfield 1.014
Ann Arbor 924
Chandler 800
Houston 619
Ashburn 614
Trieste 585
Singapore 524
Wilmington 499
Hong Kong 493
Seattle 437
Jacksonville 379
Cambridge 341
Princeton 232
Boardman 222
Munich 221
Beijing 147
Helsinki 143
Dublin 141
Moscow 137
Izmir 135
Sofia 134
Columbus 127
Santa Clara 102
Dearborn 91
Milan 66
Los Angeles 53
Brussels 51
San Diego 43
Dong Ket 42
Dakar 39
Redwood City 36
Falls Church 33
Shanghai 33
Nuremberg 30
Vienna 28
Dallas 25
Phoenix 25
The Dalles 25
Des Moines 24
Düsseldorf 24
Nanjing 24
Hefei 23
Lappeenranta 23
Bremen 22
Jinan 22
Rome 22
Tokyo 21
São Paulo 20
Seoul 19
Redmond 18
Brno 17
Guangzhou 17
New York 17
Shenyang 17
Amsterdam 16
Kunming 16
London 15
Norwalk 15
Washington 15
Bern 14
Frankfurt am Main 14
Pune 14
Fano 13
Genoa 13
Shannon 13
Istanbul 12
Sydney 12
Bologna 11
Chicago 11
Bengaluru 10
Chengdu 10
Fremont 10
Hangzhou 10
Jyväskylä 10
Kocaeli 10
Mestre 10
Nanchang 10
Paris 10
Pignone 10
Venice 10
Buffalo 9
Detroit 9
Fuzhou 9
Lauterbourg 9
Udine 9
Wuhan 9
Zhengzhou 9
Berlin 8
Chihuahua City 8
Ljubljana 8
Patna 8
Taiyuan 8
Baku 7
Changsha 7
Council Bluffs 7
Edinburgh 7
Hebei 7
Lisbon 7
Totale 13.801
Salva come PNG Salva come JPEG
Nome #
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis 438
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 410
Pharmacogenetics of thiopurines 392
5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis 379
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 376
Role of Oxidative Stress Mediated by Glutathione-S-transferase in Thiopurines' Toxic Effects 373
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children 373
BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress 369
Genetic determinants for methotrexate response in juvenile idiopathic arthritis 355
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms 353
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients 342
Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis? 338
Type i interferon-mediated autoinflammation due to DNase II deficiency 323
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia 256
Pharmacogenetics of treatments for inflammatory bowel disease 249
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 226
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease 214
Novel motif of variable number of tandem repeats in TPMT promoter region and evolutionary association of variable number of tandem repeats with TPMT∗3 alleles 212
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn's disease 209
Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy 207
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 200
Ergothioneine, a dietary amino acid with a high relevance for the interpretation of label-free surface enhanced Raman scattering (SERS) spectra of many biological samples 199
Opioid Resistance Associated with CYP3A4 Hyperactivity and COMT Polymorphism in an Oncological Patient 198
Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. 194
NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells 190
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives 190
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 189
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease. 188
Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse. 184
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events 183
Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient 182
In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome 178
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease 178
ABCB1 and ABCC1 variants associated with virological failure of first-line protease inhibitors antiretroviral regimens in Northeast Brazil patients. 175
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 174
Personalized therapies in pediatric inflammatory and autoimmune diseases. 170
Contribution of Glutathione-S-Transferases to the Pharmacogenetics of Azathioprine 170
Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? 169
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 169
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor 169
Glutathione-S-Transferase-P1 I105V polymorphism and response to antenatal betamethasone in the prevention of respiratory distress syndrome 168
SERS of cells: What can we learn from cell lysates? 168
Genetic Predictors of Glucocorticoid Response in Pediatric Patients With Inflammatory Bowel Diseases 165
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 163
Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease 159
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients 157
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 157
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort 156
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response 156
Pharmacogenomic approaches for tailored anti-leukemic therapy in children. 154
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease 153
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 152
Usefulness of the measurement of azathioprine metabolites in the assessment of non-adherence 148
Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response. 146
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay 145
Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease. 144
Letter: TPMT activity and age in IBD patients. 144
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. 143
Distinct effects of dinuclear ruthenium(III) complexes on cell proliferation and on cell cycle regulation in human and murine tumor cell lines. 141
Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease. 137
In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile 137
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients 135
Cancer Pharmacogenomics 134
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. 132
Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress 132
Pharmacogenetics, cost of genotyping, and guidelines for individualizing therapy with mercaptopurine in pediatric acute lymphoblastic leukemia. 131
Emerging molecular mechanisms underlying cancer metastasis: the rising role of the long non-coding RNA GAS5 130
ABCB1 gene polymorphisms and expression of P-glycoprotein and long term prognosis in colorectal cancer 127
Inflammatory Bowel Disease 126
Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia 123
DMET™ Plus array delivers results in good concordance with those of several lower-throughput genotyping methods in patient samples. 120
Effect of periodontal therapy on the course of cyclosporin-induced gingival overgrowth: role of ABCB1 and PAI-1 gene polymorphisms. 119
TPMT genotype and the use of thiopurines in pediatric inflammatory bowel disease. 117
Pharmacogenomics in pediatric leukemia 117
Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies 117
Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status 113
Induced pluripotent stem cells as a model for therapy personalizationof pediatric patients: Disease modeling and drug adverse effects prevention 112
Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion. 111
Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia 105
MICRORNAS ARE INVOLVED IN GLUCOCORTICOID RESISTANCE REVERSION BY RAPAMYCIN THROUGH SUPPRESSION OF THE JNK SIGNALING PATHWAY 105
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity. 104
Processes for incorporation of pharmacogenetic tests and interpretations in medical records for clinical practice. 104
Systematic identification of host genomic variation related to treatment outcome of childhood acute lymphoblastic leukemia 103
ITPA genetic polymorphism is possibly associated with survival rate in Korean children with acute lymphoblastic leukemia. 100
Pharmacogenetics of thiopurines: can posology be guided by laboratory data? 97
Thiopurine pathway 95
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway 94
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs 92
Glucocorticoid receptor polymorphisms in inflammatory bowel disease. 91
Poor response to thiopurine in inflammatory bowel disease: How to overcome therapeutic resistance? Commentary 90
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease 89
Microbiota and drug response in inflammatory bowel disease 89
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias 89
Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia 87
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention 86
Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients 84
Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease 83
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease 83
Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook 83
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 82
Totale 17.367
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.658
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.658
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020584 0 0 0 0 0 0 0 0 0 197 224 163
2020/20212.509 215 175 224 282 258 265 248 142 157 256 99 188
2021/20221.581 100 110 90 140 40 141 122 55 180 161 95 347
2022/20232.390 237 370 161 347 223 373 22 204 264 49 89 51
2023/20241.698 76 99 64 101 176 144 298 331 30 53 205 121
2024/20253.660 96 257 353 417 390 539 330 341 645 292 0 0
Totale 19.531